Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03772769 · ClinicalTrials.gov registry record · NA
Diagnostic Modalities for Severe Odontogenic Infections Using Rapid, Target Enriched Multiplex PCR (TEM- PCR) by Diatherix
A NA study of Odontogenic Deep Space Neck Infection, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03772769: Completed NA study of Odontogenic Deep Space Neck Infection, sponsored by The University of Texas Health Science Center, Houston.
NCT03772769 is a NA study of Odontogenic Deep Space Neck Infection that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03772769, a NA study of Odontogenic Deep Space Neck Infection, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the sensitivity and specificity of the Target Enriched Multiplex (TEM) polymerase chain reaction (PCR) platform for the rapid molecular diagnosis and treatment of odontogenic deep space neck infections.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Target Enriched Multiplex PCR (TEM- PCR)
- DIAGNOSTIC_TEST Microbial culture
Study Locations (1)
Texas
- Th University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2020-02-29 |
| Phase | NA |
What the finished NCT03772769 record still lists
NCT03772769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Odontogenic Deep Space Neck Infection appearing as the primary indexed condition, and to 2 interventions - of which Target Enriched Multiplex PCR (TEM- PCR) is the first listed.
NCT03772769 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03772769 about?
NCT03772769 is a clinical study titled "Diagnostic Modalities for Severe Odontogenic Infections Using Rapid, Target Enriched Multiplex PCR (TEM- PCR) by Diatherix". The purpose of the study is to evaluate the sensitivity and specificity of the Target Enriched Multiplex (TEM) polymerase chain reaction (PCR) platform for the rapid molecular diagnosis and treatment of odontogenic deep space neck infections.
What is the current status of trial NCT03772769?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-02-01. Estimated completion is 2020-02-29.
What conditions does trial NCT03772769 study?
This clinical trial studies the following conditions: Odontogenic Deep Space Neck Infection.
What interventions are being tested in trial NCT03772769?
The interventions under investigation include: Target Enriched Multiplex PCR (TEM- PCR) (DIAGNOSTIC_TEST), Microbial culture (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03772769?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03772769 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03772769's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI